.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 4,923,892

« Back to Dashboard

Claims for Patent: 4,923,892

Title: Tricyclic aromatic compounds
Abstract:The present invention relates to compounds of formula I ##STR1## or a salt, ester or amide thereof; wherein R.sup.1 is --CH.sub.2 --CH.sub.2 --, CH.sub.2 --O-- or --O--CH.sub.2 --; R.sup.2 and R.sup.3 are the same or different and are each hydrogen, C.sub.1-4 alkyl or taken together with the nitrogen comprise a nitrogen-containing heterocyclic ring having four to six ring members; R.sup.4 is a single bond or a C.sub.1-7 bivalent aliphatic hydrocarbon group and may be joined to the aromatic ring system at the 2,3,8 or 9 positions; n is 0 to 3, and their use as antihistamine and antiasthma agents.
Inventor(s): Lever, Jr.; O. William (Skillman, NJ), Leighton; Harry J. (Chapel Hill, NC)
Assignee: Burroughs Wellcome Co. (Research Triangle Park, NC)
Application Number:07/356,884
Patent Claims: 1. A method of treating allergy in a mammal which comprises administering to a mammal in need thereof an effective allergy treatment amount of a compound of formula (I) ##STR10## or a pharmacologically and pharmaceutically acceptable salt thereof; wherein R.sup.1 is --CH.sub.2 --O--, R.sup.2 and R.sup.3 are the same or different and are each hydrogen or C.sub.1-4 alkyl, R.sup.4 is a C.sub.1-2 bivalent hydrocarbon group and is joined to the aromatic ring system at the 2 position and n is 2.

2. The method of claim 1 in which R.sup.2 and R.sup.3 are methyl.

3. A method of claim 1 in which the compound of formula (I) is:

(Z)-11-(3-(Dimethylamino)propylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acryl ic acid.

4. A method of treating asthma in a mammal which comprises administering to a mammal in need thereof an effective asthma treatment amount of a compound of formula (I) ##STR11## or a pharmacologically and pharmaceutically acceptable salt thereof; wherein R.sup.1 is --CH.sub.2 --O--, R.sup.2 and R.sup.3 are the same or different and are each hydrogen or C.sub.1-4 alkyl, R.sup.4 is a C.sub.1-2 bivalent hydrocarbon group and is joined to the aromatic ring system at the 2 position and n is 2.

5. The method of claim 4 in which R.sup.2 and R.sup.3 are methyl.

6. The method of claim 4 in which the compound of formula (I) is:

(Z)-11-(3-(Dimethylamino)propylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acryl ic acid.

7. A pharmaceutical formulation for use in treating allergy or asthma comprising an effective allergy or asthma treatment amount of: ##STR12## or a pharmacologically and pharmaceutically acceptable salt thereof; wherein R.sup.1 is --CH.sub.2 --O--, R.sup.2 and R.sup.3 are the same or different and are each hydrogen or C.sub.1-4 alkyl, R.sup.4 is a C.sub.1-2 bivalent hydrocarbon group and is joined to the aromatic ring system at the 2 position and n is 2 and a pharmaceutically acceptable carrier therefore.

8. The formulation of claim 7 in which R.sup.1 and R.sup.2 are methyl.

9. The formulation of claim 8 in which the compound is:

(Z)-11-(3-(Dimethylamino)propylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acryl ic acid.

10. The formulation of claim 7 in the form of a tablet or capsule.

11. The formulation of claim 8 in the form of a tablet or capsule.

12. The formulation of claim 9 in the form of a tablet or capsule.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc